These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17896952)

  • 1. PAI-1 as a target in kidney disease.
    Huang Y; Noble NA
    Curr Drug Targets; 2007 Sep; 8(9):1007-15. PubMed ID: 17896952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis.
    Rerolle JP; Hertig A; Nguyen G; Sraer JD; Rondeau EP
    Kidney Int; 2000 Nov; 58(5):1841-50. PubMed ID: 11044203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals.
    Zhang G; Kernan KA; Collins SJ; Cai X; López-Guisa JM; Degen JL; Shvil Y; Eddy AA
    J Am Soc Nephrol; 2007 Mar; 18(3):846-59. PubMed ID: 17267741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine proteases, inhibitors and receptors in renal fibrosis.
    Eddy AA
    Thromb Haemost; 2009 Apr; 101(4):656-64. PubMed ID: 19350108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis.
    Rabieian R; Boshtam M; Zareei M; Kouhpayeh S; Masoudifar A; Mirzaei H
    J Cell Biochem; 2018 Jan; 119(1):17-27. PubMed ID: 28520219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
    Jung ES; Lee J; Heo NJ; Kim S; Kim DK; Joo KW; Han JS
    Nephrology (Carlton); 2016 Jul; 21(7):574-82. PubMed ID: 26869361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased expression of plasminogen activator inhibitor-1 in hypoxic renal injury and its pathological significance in progression of advanced renal disease].
    Kimura H
    Rinsho Byori; 2005 Aug; 53(8):749-58. PubMed ID: 16190362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis.
    Huang Y; Haraguchi M; Lawrence DA; Border WA; Yu L; Noble NA
    J Clin Invest; 2003 Aug; 112(3):379-88. PubMed ID: 12897205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease.
    Krag S; Danielsen CC; Carmeliet P; Nyengaard J; Wogensen L
    Kidney Int; 2005 Dec; 68(6):2651-66. PubMed ID: 16316341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
    Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE
    Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modulation of aberrant extracellular matrix degradation systems by astragali radix and angelicae sinensis radix decoction (A&A) in interstitial fibrotic kidney].
    Meng L; Liao A; Qu L; Tang J; Li X
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):79-84. PubMed ID: 22741467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 in kidney pathology (Review).
    Małgorzewicz S; Skrzypczak-Jankun E; Jankun J
    Int J Mol Med; 2013 Mar; 31(3):503-10. PubMed ID: 23314920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction.
    Oda T; Jung YO; Kim HS; Cai X; López-Guisa JM; Ikeda Y; Eddy AA
    Kidney Int; 2001 Aug; 60(2):587-96. PubMed ID: 11473641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling.
    He W; Tan R; Dai C; Li Y; Wang D; Hao S; Kahn M; Liu Y
    J Biol Chem; 2010 Aug; 285(32):24665-75. PubMed ID: 20519507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cellular infiltrates in response to proteinuria.
    Eddy A
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S25-9. PubMed ID: 11158857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 reduces cardiac fibrosis and promotes M2 macrophage polarization in inflammatory cardiomyopathy.
    Baumeier C; Escher F; Aleshcheva G; Pietsch H; Schultheiss HP
    Basic Res Cardiol; 2021 Jan; 116(1):1. PubMed ID: 33432417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melittin inhibits TGF-β-induced pro-fibrotic gene expression through the suppression of the TGFβRII-Smad, ERK1/2 and JNK-mediated signaling pathway.
    Park SH; Cho HJ; Jeong YJ; Shin JM; Kang JH; Park KK; Choe JY; Park YY; Bae YS; Han SM; Moon SK; Kim WJ; Choi YH; Chang YC
    Am J Chin Med; 2014; 42(5):1139-52. PubMed ID: 25178280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
    Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy.
    Rossini M; Naito T; Yang H; Freeman M; Donnert E; Ma LJ; Dunn SR; Sharma K; Fogo AB
    Nephrol Dial Transplant; 2010 Jun; 25(6):1803-10. PubMed ID: 20061322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells.
    Gesualdo L; Ranieri E; Monno R; Rossiello MR; Colucci M; Semeraro N; Grandaliano G; Schena FP; Ursi M; Cerullo G
    Kidney Int; 1999 Aug; 56(2):461-70. PubMed ID: 10432384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.